Critical Care Diagnostics Market Analysis By Test Type (Routine & Special Chemistry, Flow Cytometry, Hematology, Immunoproteins, Microbial and Infectious Diseases, Coagulation Testing), By End-use type (Operation Rooms, Emergency Rooms, Intensive Care Units), By Region (U.S., Canada, Germany, UK, China, India, Brazil, Mexico, South Africa) And Segment Forecasts To 2024

Published: Aug, 2016 | Pages: 77 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

The global critical care diagnostics market is expected to reach USD 1.29 billion by 2024, according to a new report by Grand View Research, Inc. The critical care diagnostics market is expected to grow at a lucrative rate in the next few years. The key factors supporting the industry's growth comprise the rapid awareness and acknowledgment of these tests by physicians and patients, the rise in geriatric population and chronic health conditions, the employment of telehealth services in remote areas, and technological advancements. The increased cost of the molecular diagnostics and dearth of skilled labor are factors that are expected to hinder the growth of the industry.

The critical care diagnostics market by test type is categorized into routine and special chemistry, flow cytometry, hematology, immunoproteins, microbial and infectious diseases, coagulation testing, and others. The microbial and infectious diseases test diagnostics segment is projected to grow at the highest rate with a CAGR of over 5% during the forecast period. For example, healthcare systems spend a substantial amount of resources in the collection and processing of blood cultures for the identification of pathogens.

Critical care diagnostic tests, such as the nucleic acid amplification test, allow clinicians to detect and identify organisms more rapidly and accurately and provide guidance to clinicians, who aspire to commence the appropriate antimicrobial therapy as fast as possible and terminate the use of avoidable drugs. The critical care diagnostic market by the end-user is categorized into operation rooms, emergency rooms, and ICU's. The emergency rooms segment in the industry is anticipated to witness the highest growth rate during the forecast period.

Further key findings from the study suggest:

The Asia Pacific region is estimated to dominate the critical care market in terms of the highest growth rate, with a CAGR of around 9.1% during the forecast period. The large presence of geriatric population, increasing prevalence of chronic diseases, increase in the number of specialty hospitals in the Asia Pacific region, and improving healthcare services and infrastructures in rural areas are the factors fueling the market growth.

The immunoproteins diagnostic test segment is estimated to account for the largest share of the critical care diagnostic market by type. The rise in demand for rapid and accurate preventive healthcare services is one of the major factors driving this market growth.

On the basis of end-users, approximately 20% of acute-care patients get admitted into ICU's, whereas nearly 58% get admitted into emergency rooms. The emergency rooms are expected to witness exponential growth with the highest CAGR during the forecast period. The recent rise in the patient demand for ER services is due to its ability to provide initial acute care diagnosis and treatment of critically ill patients.

Some major players in this industry include Abbott., Alere, Inc., Beckman-Coulter, Roche Diagnostics, and Becton Dickinson & Co., among others.

 Table of Contents


Chapter 1 Methodology and Scope
                   1.1. Research methodology
                   1.2. Research scope & assumption
                   1.3. List of data sources
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends & Scope
                   4.1. Market segmentation
                   4.2. Market size and growth prospects, 2013 - 2024
                   4.3. Critical care diagnostics: Market dynamics
                      4.3.1. Market Driver Analysis
                            4.3.1.1. Growing patient demand for rapid diagnosis and treatment
                            4.3.1.2. Increasing geriatric population
                            4.3.1.3. Telehealth and remote communications between diagnostics and laboratories
                      4.3.2. Market Restraint Analysis
                            4.3.2.1. Increased cost of diagnostics tools and dearth of skilled labor
                   4.4. Penetration & growth prospect mapping
                   4.5. Critical Care Diagnostics Company - SWOT analysis, by factor (political &legal, economic and technological)
                   4.6. Industry Analysis - Porter's
Chapter 5. Market Categorization 1: Type Estimates & Trend Analysis
                   5.1. Critical care diagnostics market: Type movement analysis
                      5.1.1. Routine and special chemistry 
                            5.1.1.1. Routine and special chemistry market estimates and forecasts, 2013 - 2024 (USD Million)
                      5.1.2. Flow cytometry 
                            5.1.2.1. Flow cytometry market estimates and forecasts, 2013 - 2024 (USD Million)
                      5.1.3. Hematology
                            5.1.3.1. Hematology market estimates and forecasts, 2013 - 2024 (USD Million)
                      5.1.4. Microbial and infectious test 
                            5.1.4.1. Microbial and infectious test market estimates and forecasts, 2013 - 2024 (USD Million)
                      5.1.5. Coagulation 
                            5.1.5.1. Coagulation market estimates and forecasts, 2013 - 2024 (USD Million)
                      5.1.6. Others
                            5.1.6.1. Other market estimates and forecasts, 2013 - 2024 (USD Million)
Chapter 6. Market Categorization 2: End-User Estimates & Trend Analysis
                   6.1. Critical care diagnostics market: End-user movement analysis
                      6.1.1. Operating rooms
                            6.1.1.1. Operating rooms market estimates and forecasts, 2013 - 2024 (USD Million)
                      6.1.2. Emergency rooms
                            6.1.2.1. Emergency rooms market estimates and forecasts, 2013 - 2024 (USD Million)
                      6.1.3. Intensive care units
                            6.1.3.1. Intensive care units market estimates and forecasts, 2013 - 2024 (USD Million)
                      6.1.4. Others
                            6.1.4.1. Other market estimates and forecasts, 2013 - 2024 (USD Million)
Chapter 7. Market Categorization 3: Regional Estimates & Trend Analysis, by Type & End-User
                   7.1. Critical care diagnostics market share by region, 2016 & 2024 
                      7.1.1. North America 
                            7.1.1.1. U.S. market estimates and forecasts, by type, 2013 - 2024 (USD Million) 
                            7.1.1.2. U.S. market estimates and forecasts, by end-user, 2013 - 2024 (USD Million)
                            7.1.1.3. Canada market estimates and forecasts, by type, 2013 - 2024 (USD Million) 
                            7.1.1.4. Canada market estimates and forecasts, by end-user, 2013 - 2024 (USD Million) 
                      7.1.2. Europe 
                            7.1.2.1. Germany market estimates and forecasts by type, 2013 - 2024 (USD Million) 
                            7.1.2.2. Germany market estimates and forecasts, by end-user, 2013 - 2024 (USD Million) 
                            7.1.2.3. UK market estimates and forecasts, by type, 2013 - 2024 (USD Million) 
                            7.1.2.4. UK market estimates and forecasts, by end-user, 2013 - 2024 (USD Million) 
                      7.1.3. Asia Pacific 
                            7.1.3.1. China market estimates and forecasts, by type, 2013 - 2024 (USD Million) 
                            7.1.3.2. China market estimates and forecasts, by end-user, 2013 - 2024 (USD Million) 
                            7.1.3.3. India market estimates and forecasts, by type, 2013 - 2024 (USD Million) 
                            7.1.3.4. India market estimates and forecasts, by end-user, 2013 - 2024 (USD Million)
                      7.1.4. Latin America
                            7.1.4.1. Mexico estimates and forecasts, by type, 2013 - 2024 (USD Million) 
                            7.1.4.2. Mexico estimates and forecasts, by end-user, 2013 - 2024 (USD Million) 
                            7.1.4.3. Brazil estimates and forecasts, by type, 2013 - 2024 (USD Million) 
                            7.1.4.4. Brazil estimates and forecasts, by end-user, 2013 - 2024 (USD Million) 
                      7.1.5. MEA 
                            7.1.5.1. South Africa estimates and forecasts, by type, 2013 - 2024 (USD Million) 
                            7.1.5.2. South Africa estimates and forecasts, by end-user,2013 - 2024 (USD Million)
                            7.1.5.3. Saudi Arabia estimates and forecasts, by type, 2013 - 2024 (USD Million) 
                            7.1.5.4. Saudi Arabia estimates and forecasts, by end-user, 2013 - 2024 (USD Million) 
Chapter 8. Competitive Landscape 
                   8.1. Strategy framework
                   8.2. Market participation categorization
                   8.3. Company Profiles
                      8.3.1. Abbott
                            8.3.1.1. Company Overview
                            8.3.1.2. Financial Performance
                            8.3.1.3. Product Benchmarking
                            8.3.1.4. Strategic Initiatives
                      8.3.2. Alere, Inc.
                            8.3.2.1. Company Overview
                            8.3.2.2. Financial Performance
                            8.3.2.3. Product Benchmarking
                            8.3.2.4. Strategic Initiatives
                      8.3.3. Beckman-Coulter/ Danaher
                            8.3.3.1. Company Overview
                            8.3.3.2. Financial Performance
                            8.3.3.3. Product Benchmarking
                            8.3.3.4. Strategic Initiatives
                      8.3.4. Roche Diagnostics Ltd.
                            8.3.4.1. Company Overview
                            8.3.4.2. Financial Performance
                            8.3.4.3. Product Benchmarking
                            8.3.4.4. Strategic Initiatives
                      8.3.5. Becton Dickinson & Co.
                            8.3.5.1. Company Overview
                            8.3.5.2. Financial Performance
                            8.3.5.3. Product Benchmarking
                            8.3.5.4. Strategic Initiatives
                      8.3.6. EKF Diagnostics
                            8.3.6.1. Company Overview
                            8.3.6.2. Financial Performance
                            8.3.6.3. Product Benchmarking
                            8.3.6.4. Strategic Initiatives
                      8.3.7. BioMerieux, Inc.
                            8.3.7.1. Company Overview
                            8.3.7.2. Financial Performance
                            8.3.7.3. Product Benchmarking
                            8.3.7.4. Strategic Initiatives
                      8.3.8. Siemens Healthcare Diagnostics
                            8.3.8.1. Company Overview
                            8.3.8.2. Financial Performance
                            8.3.8.3. Product Benchmarking
                            8.3.8.4. Strategic Initiatives
                      8.3.9. Chembio Diagnostic Systems, Inc.
                            8.3.9.1. Company Overview
                            8.3.9.2. Financial Performance
                            8.3.9.3. Product Benchmarking
                            8.3.9.4. Strategic Initiatives
                      8.3.10. Bayer Healthcare AG
                            8.3.10.1. Company Overview
                            8.3.10.2. Financial Performance
                            8.3.10.3. Product Benchmarking
                            8.3.10.4. Strategic Initiatives

List of Tables


1. North America critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
2. North America critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million)
3. U.S. critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
4. U.S. critical care diagnostics market revenue, by end-user application, 2016 - 2024 (USD Million) 
5. Canada critical care diagnostics market revenue, by test type, 2016 - 2024 (USD Million)
6. Canada critical care diagnostics market revenue, by end-user application, 2016 - 2024 (USD Million) 
7. Europe critical care diagnostics market revenue, by test type, 2016 - 2024 (USD Million)
8. Europe critical care diagnostics market revenue, by end-user application, 2016 - 2024 (USD Million)
9. Germany critical care diagnostics market revenue, by test type, 2016 - 2024 (USD Million)
10. Germany critical care diagnostics market revenue, by end-user application, 2016 - 2024 (USD Million) 
11. UK critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
12. UK critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million)
13. Asia Pacific critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million) 
14. Asia Pacific critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million) 
15. China critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million) 
16. China critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million)
17. India critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million) 
18. India critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million) 
19. Latin America critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million) 
20. Latin America critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million)
21. Brazil critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million) 
22. Brazil critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million) 
23. Mexico critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
24. Mexico critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million) 
25. MEA critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million) 
26. MEA critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million)
27. South Africa critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million) 
28. South Africa critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million)
29. Saudi Arabia critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million) 
30. Saudi Arabia critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million)